HPLC-fluorescence assay for measuring mosapride in small volumes of rat plasma.

A simple and sensitive HPLC-fluorescence assay was developed for the determination of a gastroprokinetic agent mosapride in small volumes of rat plasma. Samples (50 microL) were treated with 200 microL of the internal standard solution (cisapride, 0.1 microg/mL in acetonitrile). Chromatographic separation was achieved on a C(18) column by gradient elution with the mobile phase of acetonitrile-water containing 20 mM potassium dihydrogen phosphate, at a flow rate of 1 mL/min. Fluorescence was measured with excitation and emission set at 315 and 354 nm, respectively. The retention time was about 16 min for cisapride and 20 min for mosapride. No endogenous substances were found to interfere. The calibration curve was linear from 0.015 to 10 microg/mL. The lower limit of quantification was 0.015 microg/mL. The intra- and inter-day precision expressed as relative standard deviation did not exceed 7.7%, and the accuracy was within 4.7% deviation of the nominal concentration. The method was used successfully to investigate the disposition kinetics of mosapride in rats.

[1]  Fa-mei Li,et al.  Characterization of metabolic profile of mosapride citrate in rat and identification of two new metabolites: Mosapride N-oxide and morpholine ring-opened mosapride by UPLC-ESI-MS/MS. , 2009, Journal of pharmaceutical and biomedical analysis.

[2]  A. Kotani,et al.  Liquid chromatography-tandem mass spectrometric method for determination of mosapride citrate in equine tissues. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[3]  Feng Qin,et al.  [Determination of mosapride in human plasma by high performance liquid chromatography tandem mass spectrometry]. , 2007, Yao xue xue bao = Acta pharmaceutica Sinica.

[4]  C. Chou,et al.  Development and validation of a high-performance liquid chromatographic method using fluorescence detection for the determination of vardenafil in small volumes of rat plasma and bile. , 2007, Journal of chromatography. A.

[5]  Y. Nakajima,et al.  Enhancement of the intrinsic defecation reflex by mosapride, a 5-HT4 agonist, in chronically lumbosacral denervated guinea pigs. , 2006, Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi.

[6]  R. Nageswara Rao,et al.  Enantioselective determination of a gastroprokinetic drug using amylose tris-(3,5-dimethylphenylcarbamate) as a stationary phase by HPLC. , 2006, Journal of pharmaceutical and biomedical analysis.

[7]  N. V. Ramakrishna,et al.  Validation and application of a high-performance liquid chromatography--tandem mass spectrometry assay for mosapride in human plasma. , 2005, Biomedical chromatography : BMC.

[8]  C. Chou,et al.  Determination of tadalafil in small volumes of plasma by high-performance liquid chromatography with UV detection. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[9]  O. Y. Hu,et al.  Determination of lamotrigine in small volumes of plasma by high-performance liquid chromatography. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[10]  S. Alvi,et al.  Development and validation of a liquid chromatographic method for determination of related-substances of mosapride citrate in bulk drugs and pharmaceuticals. , 2004, Journal of pharmaceutical and biomedical analysis.

[11]  C. Chou,et al.  Rapid and sensitive quantitation of the antiproliferative agent mitoguazone in small volumes of plasma by high-performance liquid chromatography with ultraviolet detection. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[12]  H. Saitoh,et al.  Drug interaction between mosapride and erythromycin without electrocardiographic changes. , 2003, Japanese heart journal.

[13]  T. K. Murthy,et al.  A validated RP-HPLC method for the determination of mosapride citrate in bulk drug samples and pharmaceutical formulations. , 2002, Die Pharmazie.

[14]  T. K. Murthy,et al.  The Determination of Mosapride Citrate in Bulk Drug Samples and Pharmaceutical Dosage Forms Using HPLC , 2002, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.

[15]  C. Chou,et al.  Determination of delavirdine in very small volumes of plasma by high-performance liquid chromatography with fluorescence detection. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[16]  T. Mushiroda,et al.  The involvement of flavin-containing monooxygenase but not CYP3A4 in metabolism of itopride hydrochloride, a gastroprokinetic agent: comparison with cisapride and mosapride citrate. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[17]  Y. Mizuki,et al.  Simultaneous enantiomeric determination of a gastroprokinetic agent mosapride citrate and its metabolite in plasma using alpha 1-acid glycoprotein HPLC column. , 1997, Journal of pharmaceutical and biomedical analysis.

[18]  Y. Mizuki,et al.  Pharmacokinetics of the gastrokinetic agent mosapride citrate after intravenous and oral administrations in rats. , 1993, Arzneimittel-Forschung.

[19]  H Miyazaki,et al.  Pharmacokinetics of the gastrokinetic agent mosapride citrate after single and multiple oral administrations in healthy subjects. , 1993, Arzneimittel-Forschung.

[20]  M. Patel,et al.  High-performance liquid chromatography and thin-layer chromatography for the simultaneous quantitation of rabeprazole and mosapride in pharmaceutical products. , 2008, Journal of chromatographic science.

[21]  D. M. Robinson,et al.  Mosapride in gastrointestinal disorders. , 2008, Drugs.

[22]  A. Asakawa,et al.  Mosapride improves food intake, while not worsening glycemic control and obesity, in ob/ob obese mice with decreased gastric emptying. , 2006, Journal of diabetes and its complications.